Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) announced that the Company
will release results for its first quarter of Fiscal Year 2014 ended
July 31, 2013, prior to the market opening on Monday September 9, 2013
and will hold a conference call to discuss its financial results at 10
a.m. Eastern Time.
To access the conference call, dial toll free 877-415-3182, or
857-244-7325 for international callers, five minutes before the
conference. The passcode of the conference call is 69737154.
A replay of the conference call will be available after 12:00 p.m. on
September 9, 2013, for one week by calling toll free 888-286-8010, or
617-801-6888 for international callers. The passcode for the replay is
85541072. The call can also be accessed on the Investor Relations page
on the Company’s website www.hitechpharm.com.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing
and marketing generic and branded prescription and OTC products. The
Company specializes in difficult to manufacture liquid and semi-solid
dosage forms and produces a range of sterile ophthalmic, otic and
inhalation products. The Company’s Health Care Products Division is a
leading developer and marketer of branded OTC products for the diabetes
marketplace. Hi-Tech’s ECR Pharmaceuticals subsidiary markets branded
prescription products.
This press release contains certain future projections and
forward-looking statements (statements which are not historical facts)
with respect to the anticipated future performance of Hi-Tech made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such future projections and
forward-looking statements are not assurances, promises or guarantees
and investors are cautioned that all future projections and
forward-looking statements involve significant business, economic and
competitive risks and uncertainties, many of which are beyond Hi-Tech's
ability to control or estimate precisely, including, but not limited to,
the impact of competitive products and pricing, product demand and
market acceptance, new product development, the regulatory environment,
including without limitation, reliance on key strategic alliances,
availability of raw materials, fluctuations in operating results, loss
of customers or employees, the possibility that legal proceedings may be
instituted against Hi-Tech and other results and other risks detailed
from time to time in Hi-Tech’s filings with the Securities and Exchange
Commission. The actual results will vary from the projected results and
such variations may be material. These statements are based on
management's current expectations and assumptions concerning the future
performance of Hi-Tech and are naturally subject to uncertainty and
changes in circumstances. No representations or warranties are made as
to the accuracy or completeness of any of the information contained
herein, including, but not limited to, any assumptions or projections
contained herein or forward-looking statements based thereon. We caution
you not to place undue reliance upon any such forward-looking statements
which speak only as of the date made, except to the extent specifically
dated as of an earlier date. Hi-Tech is under no obligation, and
expressly disclaims any such obligation, to update, alter or correct any
inaccuracies herein, whether as a result of new information, future
events or otherwise.
Copyright Business Wire 2013